Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Yoshifumi Saisho
Combined with clinical oversight and our lowest-effective-dose medication philosophy, this approach delivers: 16.7% average weight loss in 12 months , based on internal clinical outcomes 66% lower GLP-1 medication use , by starting low and escalating only if needed 8 in 10 members taper off medication without regaining weight , thanks to sustainable behavior change These outcomes demonstrate that coaching-based weight loss programs are not only clinically effective but also financially responsible
Clinical trials show 15-22% total body weight loss with tirzepatide and 12-17% with semaglutide over 72 weeks
Try eating smaller meals more often throughout the day
